ICU MEDICAL INC/DE Interest Expense, Debt, Excluding Amortization
ICU MEDICAL INC/DE (ICUI) reported Interest Expense, Debt, Excluding Amortization of $18.18 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseDebtExcludingAmortization · last filed 2026-08-06
- ICU MEDICAL INC/DE interest expense, debt, excluding amortization for the quarter ending 2026-06-30 was $18.18M, a 23.81% decline year-over-year.
- ICU MEDICAL INC/DE interest expense, debt, excluding amortization for the quarter ending 2026-03-31 was $18.22M, a 32.22% decline year-over-year.
- ICU MEDICAL INC/DE interest expense, debt, excluding amortization for the quarter ending 2025-12-31 was $20.32M, a 29.52% decline year-over-year.
- ICU MEDICAL INC/DE interest expense, debt, excluding amortization for the quarter ending 2025-09-30 was $22.82M, a 28.83% decline year-over-year.
- ICU MEDICAL INC/DE interest expense, debt, excluding amortization for fiscal 2025 was $93.89M, a 24.90% decline from fiscal 2024.
- ICU MEDICAL INC/DE interest expense, debt, excluding amortization for fiscal 2024 was $125.01M, a 0.43% decline from fiscal 2023.
- ICU MEDICAL INC/DE interest expense, debt, excluding amortization for fiscal 2023 was $125.55M, a 88.03% increase from fiscal 2022.
- ICU MEDICAL INC/DE interest expense, debt, excluding amortization for fiscal 2022 was $66.77M.
| Period end | Interest Expense, Debt, Excluding Amortization 3 month | Interest Expense, Debt, Excluding Amortization 6 month | Interest Expense, Debt, Excluding Amortization 9 month | Interest Expense, Debt, Excluding Amortization 12 month |
|---|---|---|---|---|
| 2026-06-30 | $18.18M 10-Q · filed 2026-08-06 | $36.41M 10-Q · filed 2026-08-06 | $56.73M derived: sum of 3 quarters · filed 2026-08-06 | $79.54M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $18.22M 10-Q · filed 2026-05-07 | $38.54M derived: sum of 2 quarters · filed 2026-05-07 | $61.36M derived: sum of 3 quarters · filed 2026-05-07 | $85.22M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $20.32M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $43.13M derived: sum of 2 quarters · filed 2026-02-19 | $67.00M derived: sum of 3 quarters · filed 2026-08-06 | $93.89M 10-K · filed 2026-02-19 |
| 2025-09-30 | $22.82M 10-Q · filed 2025-11-06 | $46.68M derived: sum of 2 quarters · filed 2026-08-06 | $73.57M 10-Q · filed 2025-11-06 | $102.40M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $23.87M 10-Q · filed 2026-08-06 | $50.76M 10-Q · filed 2026-08-06 | $79.58M derived: sum of 3 quarters · filed 2026-08-06 | $111.64M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $26.89M 10-Q · filed 2026-05-07 | $55.71M derived: sum of 2 quarters · filed 2026-05-07 | $87.77M derived: sum of 3 quarters · filed 2026-05-07 | $119.62M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $28.83M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $60.88M derived: sum of 2 quarters · filed 2026-02-19 | $92.74M derived: sum of 3 quarters · filed 2026-02-19 | $125.01M 10-K · filed 2026-02-19 |
| 2024-09-30 | $32.06M 10-Q · filed 2025-11-06 | $63.91M derived: sum of 2 quarters · filed 2025-11-06 | $96.19M 10-Q · filed 2025-11-06 | $129.14M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | $31.85M 10-Q · filed 2025-08-07 | $64.13M 10-Q · filed 2025-08-07 | $97.08M derived: sum of 3 quarters · filed 2026-02-19 | $129.58M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | $32.28M 10-Q · filed 2025-05-08 | $65.23M derived: sum of 2 quarters · filed 2026-02-19 | $97.73M derived: sum of 3 quarters · filed 2026-02-19 | $128.56M derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | $32.96M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $65.45M derived: sum of 2 quarters · filed 2026-02-19 | $96.29M derived: sum of 3 quarters · filed 2026-02-19 | $125.55M 10-K · filed 2026-02-19 |
| 2023-09-30 | $32.49M 10-Q · filed 2024-11-12 | $63.33M derived: sum of 2 quarters · filed 2024-11-12 | $92.59M 10-Q · filed 2024-11-12 | $117.50M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $30.84M 10-Q · filed 2024-08-07 | $60.10M 10-Q · filed 2024-08-07 | $85.00M derived: sum of 3 quarters · filed 2025-02-27 | $104.23M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $29.26M 10-Q · filed 2024-05-07 | $54.16M derived: sum of 2 quarters · filed 2025-02-27 | $73.39M derived: sum of 3 quarters · filed 2025-02-27 | $86.02M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $24.90M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $44.13M derived: sum of 2 quarters · filed 2025-02-27 | $56.75M derived: sum of 3 quarters · filed 2025-02-27 | $66.77M 10-K · filed 2025-02-27 |
| 2022-09-30 | $19.23M 10-Q · filed 2023-11-06 | $31.85M derived: sum of 2 quarters · filed 2023-11-06 | $41.87M 10-Q · filed 2023-11-06 | $41.87M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $12.62M 10-Q · filed 2023-08-07 | $22.64M 10-Q · filed 2023-08-07 | $22.64M derived: sum of 3 quarters · filed 2024-02-27 | $22.64M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $10.02M 10-Q · filed 2023-05-09 | $10.02M derived: sum of 2 quarters · filed 2024-02-27 | $10.02M derived: sum of 3 quarters · filed 2024-02-27 | $10.02M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $0.00 derived: sum of 2 quarters · filed 2024-02-27 | $0.00 derived: sum of 3 quarters · filed 2024-02-27 | $0.00 10-K · filed 2024-02-27 |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-07 | $0.00 derived: sum of 2 quarters · filed 2022-11-07 | $0.00 10-Q · filed 2022-11-07 | |
| 2021-06-30 | $0.00 10-Q · filed 2022-08-09 | $0.00 10-Q · filed 2022-08-09 | ||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-09 | |||
| 2020-12-31 | $1.25M 10-K · filed 2023-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |